CURE Pharmaceutical is a firm that conducts extensive research on how cannabinoid can be used to treat people who are affected by various health conditions. According to their latest investigations, researchers identified that cannabinoid could treat cancer among kids in an efficient manner.
CURE Pharmaceuticals would not get the sole credit for this amazing discovery. That’s because the team got into a partnership with Technion Research and Development Foundation and CannaKids to move forward with the research. In this collaborative effort, many different compounds of cannabinoid were tested to figure out how it could treat kids who are affected by cancers. According to these experiments, people who are dealing with cancer were promised to find a perfect match of the cannabis strains, which can help them to minimize the symptoms associated with the health condition.
The CEO of CannaKids, Tracy Ryan is confident about the amazing health benefits that are offered by cannabis. As a result, he firmly believes that it can be used to come up with medicine, which can treat cancer cases among kids. Moreover, he is impressed with the opportunity that he has received to work hand in hand with few of the brilliant minds, with the objective of finding a cure for cancer among kids. However, the team is not just looking forward to finding a cancer cure for children. They have paid particular attention towards children because they believe that it would be an ideal milestone with which to start. Based on the results, the team would be focusing on developing a more advanced form of the treatment, which can benefit adults as well.
The Technion team is currently working hard on their experiments in Israel. Ryan got the opportunity to go all the way to Israel and to witness how researchers are conducting these tests. In fact, Ryan’s daughter is also affected with a rare brain tumor, and he is motivated to find a cure, which can work efficiently on all the little ones who are suffering from unbearable pain. Cannabis has been able to deliver promising results to him, and he actively thinks that he has reached one step closer to his end objective by making the decision to move forward with experiments using cannabis.
Rob Davidson, who is the CEO of CURE Pharmaceuticals, is also impressed with the way how researches are being carried out at the moment. He has officially announced that studying the antitumor effects that can be found in terpenes and phytocannabinoids of cannabis can enhance the options for drugs, which can be used as cancer treatments. Also, these options can deliver informed treatment options to the patients as well. We will be able to see the results of these collaborative efforts in the future. All we can do now is to keep our fingers crossed and hope for the best outcomes.